Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways
Author:
Affiliation:
1. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
2. Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,General Medicine
Link
http://academic.oup.com/carcin/article-pdf/39/5/681/24774132/bgy038.pdf
Reference39 articles.
1. Occurrence of desmoids in patients with familial adenomatous polyposis of the colon;Klemmer;Am. J. Med. Genet,1987
2. Desmoid tumors: a report of thirty-one cases;Nichols;Arch. Surg,1932
3. Desmoid tumors in patients with familial adenomatous polyposis;Rodriguez-Bigas;Cancer,1994
4. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors;Hansmann;Cancer,2004
5. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate;Mace;Cancer,2002
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. M2 macrophage exosomes promote resistance to sorafenib in hepatocellular carcinoma cells via miR-200c-3p;International Immunopharmacology;2024-09
2. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway;World Journal of Surgical Oncology;2024-05-18
3. Artemisia sieberi Besser essential oil inhibits the growth and migration of breast cancer cells via induction of S-phase arrest, caspase-independent cell death and downregulation of ERK;Journal of Ethnopharmacology;2023-08
4. Multiple targets modulation of Bcl-2/CD1, caspase-3 and refinement of AKT/ERK signalling by sorafenib in hepatocellular carcinoma in rats; comprehensive outlook;Egyptian Pharmaceutical Journal;2023-07
5. A pilot study evaluating the use of sirolimus in children and young adults with desmoid‐type fibromatosis;Pediatric Blood & Cancer;2023-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3